abstract |
The present invention relates to pyrazoloquinazolones and pyrroloquinazolone derivatives of general formula (I), as well as pharmaceutical compositions containing them, and glutamine for their treatment and/or prevention and modification in mammals Use in disorders related to acidergic signaling and/or function and/or disorders which may be affected by altered glutamate levels or signaling, in particular in the treatment and/or prophylaxis of acute and chronic neurological and/or psychiatric disorders use in learning disabilities. |